🇺🇸 FDA
Pipeline program

Irinotecan Accord 20 mg/ml concentraat voor oplossing voor infusie

Phase 2 small_molecule active

Quick answer

Irinotecan Accord 20 mg/ml concentraat voor oplossing voor infusie for Gastric peritoneal metastases is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
Gastric peritoneal metastases
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials